# Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Article · Robert M. Samstein, Chung‐Han Lee, Alexander Noor Shoushtari, Matthew David Hellmann, Ronglai Shen, Yelena Yuriy Janjigian, David A. Barron, Ahmet Zehir, Emmet Jordan, Antonio M. P. Omuro, Thomas Joseph Kaley, Sviatoslav M. Kendall, Robert John Motzer, A. Ari Hakimi, Martin Henner Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat A Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi and 32 more

- Archive id: doi:10.1038/s41588-018-0312-8
- Published: 2019-01-08
- Venue: Nature Genetics
- DOI: https://doi.org/10.1038/s41588-018-0312-8
- PMID: 30643254
- Citations: 4,069
- Source URL: https://doi.org/10.1038/s41588-018-0312-8
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.